<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0, maximum-scale=1.0" name="viewport"/>
<title>Kaiser Permanente Largo Lab - Coagulation Testing Standard Operating Procedure</title>
<style>
/* Optimized Kaiser Permanente Laboratory SOP Template */
*{margin:0;padding:0;box-sizing:border-box}
@page{size:8.5in 11in;margin:0.75in}
html{font-size:10pt;width:100%;overflow-x:hidden}
body{font-family:Arial,sans-serif;font-size:10pt;line-height:1.5;color:#333;max-width:8.5in;margin:0 auto;padding:0.5in;background:#f5f5f5;word-wrap:break-word;overflow-wrap:break-word}
.container{background:#fff;padding:30px;border-radius:8px;box-shadow:0 0 10px rgba(0,0,0,0.1);max-width:100%;margin:0;word-wrap:break-word;overflow-wrap:break-word}

/* Header Styling */
.header{text-align:center;border-bottom:3px solid #0066cc;padding-bottom:15px;margin-bottom:25px}
.header h1{color:#0066cc;font-size:20pt;margin-bottom:8px;font-weight:bold}
.header h2{color:#666;font-size:12pt;margin:0;font-weight:normal}

/* Table of Contents - Two Column Layout */
.toc{background:#f0f8ff;padding:15px;border-left:4px solid #0066cc;margin-bottom:25px;border-radius:4px;page-break-after:always}
.toc h3{color:#0066cc;margin-top:0;font-size:12pt;margin-bottom:10px}
.toc-columns{display:flex;gap:30px}
.toc-column{flex:1}
.toc ul{list-style:none;padding:0}
.toc li{margin:6px 0;padding-left:15px}
.toc a{color:#0066cc;text-decoration:none;font-weight:500}
.toc a:hover{text-decoration:underline}

/* Section Styling */
.section{margin:30px 0;border-bottom:1px solid #e0e0e0;padding-bottom:20px}
.section:last-child{border-bottom:none}

/* Headings - Compact Styling */
h1,h2{color:#0066cc;font-size:14pt;margin-bottom:15px;border-bottom:2px solid #0066cc;padding-bottom:6px;page-break-after:avoid}
h3{color:#004499;font-size:11pt;margin:20px 0 12px 0;page-break-after:avoid}
h4{color:#333;font-size:10pt;margin:15px 0 8px 0;font-weight:bold}

/* Text Elements */
p{margin:8px 0;text-align:left;word-wrap:break-word;overflow-wrap:break-word;hyphens:auto}
ul,ol{margin:8px 0 8px 25px;padding:0;word-wrap:break-word;overflow-wrap:break-word}
li{margin:4px 0;line-height:1.5;word-wrap:break-word;overflow-wrap:break-word;hyphens:auto}

/* Special Sections */
.key-concept{background:#e3f2fd;border-left:4px solid #2196f3;padding:15px;margin:15px 0;border-radius:4px}
.procedure-section{background:#f9f9f9;padding:15px;border-radius:6px;margin:15px 0;border-left:3px solid #28a745;page-break-inside:avoid}
.warning,.warning-box{background:#fff3cd;border:1px solid #ffeaa7;border-left:3px solid #f39c12;padding:12px;margin:12px 0;border-radius:4px;page-break-inside:avoid}
.info-box{background:#d1ecf1;border:1px solid #bee5eb;border-left:3px solid #17a2b8;padding:12px;margin:12px 0;border-radius:4px;page-break-inside:avoid}
.critical-box{background:#fff5f5;border:2px solid #ff6b6b;border-radius:6px;padding:18px;margin:18px 0;page-break-inside:avoid}
.critical-values{background:#f8d7da;border:2px solid #f5c6cb;border-radius:6px;padding:15px;margin:18px 0;page-break-inside:avoid}

/* Table Styling */
table{width:100%;border-collapse:collapse;margin:20px 0;font-size:9pt;box-shadow:0 1px 3px rgba(0,0,0,0.1);border-radius:6px;overflow:hidden;background:#fff}
table thead{background:linear-gradient(135deg,#e8f4f8 0%,#d1e7f3 100%)}
table th{color:#000;padding:10px 8px;text-align:left;font-weight:600;letter-spacing:0.3px;border-right:1px solid rgba(0,0,0,0.1)}
table tbody tr{border-bottom:1px solid #e0e0e0}
table td{padding:8px;border-right:1px solid #e0e0e0}
table tbody tr:nth-child(even){background:#f8f9fa}

/* Print Optimizations */
@media print{
    @page{size:8.5in 11in;margin:0.75in}
    body{background:#fff;margin:0;padding:0;max-width:100%;font-size:9pt}
    .container{box-shadow:none;border-radius:0;padding:0;max-width:100%;margin:0}
    h1,h2,h3,h4{page-break-after:avoid}
    .toc{page-break-after:always}
}

    /* Kaiser Palette Harmonization */
    html, body {
        background-color: #f5f5f5;
        color: #333333;
    }
    body {
        min-height: 100vh;
        margin: 0 auto;
    }
    .container, .main-container, .kp-container, .content-wrapper {
        background-color: #ffffff;
        border-radius: 10px;
        box-shadow: 0 0 15px rgba(0,0,0,0.1);
        padding: 25px;
    }
    .header, .kp-header, header {
        border-bottom: 3px solid #0066cc;
        padding-bottom: 15px;
        margin-bottom: 20px;
    }
    .header h1, .kp-header h1, h1 {
        color: #0066cc !important;
    }
    h2 {
        color: #0066cc !important;
        border-bottom: 2px solid #0066cc;
        padding-bottom: 6px;
    }
    h3 {
        color: #004499 !important;
    }
    table {
        background-color: #ffffff !important;
        border-collapse: collapse;
    }
    th {
        background-color: #f0f8ff !important;
        color: #0066cc !important;
    }
    .toc {
        background-color: #f0f8ff;
        border-left: 4px solid #0066cc;
    }
    @media print {
        html, body {
            background-color: #ffffff !important;
        }
        .container, .main-container, .kp-container, .content-wrapper {
            box-shadow: none !important;
            border-radius: 0 !important;
            background-color: #ffffff !important;
        }
    }
</style>
</head>
<body>
<div class="container">

<!-- HEADER -->
<div class="header">
<h1>COAGULATION TESTING</h1>
<h2>Standard Operating Procedure - Hemostasis Laboratory</h2>
<p><strong>Document ID:</strong> LAB-COAG-001 | <strong>Version:</strong> 7.0 | <strong>Effective Date:</strong> January 2025</p>
<p><strong>Location:</strong> Largo Laboratory | <strong>Department:</strong> Coagulation/Hemostasis</p>
</div>

<!-- TABLE OF CONTENTS -->
<div class="toc">
<h3>TABLE OF CONTENTS</h3>
<div class="toc-columns">
<div class="toc-column">
<ul>
<li><a href="#purpose">1. PURPOSE</a></li>
<li><a href="#clinical">2. CLINICAL SIGNIFICANCE</a></li>
<li><a href="#scope">3. SCOPE</a></li>
<li><a href="#responsibilities">4. RESPONSIBILITIES</a></li>
<li><a href="#safety">5. SAFETY REQUIREMENTS</a></li>
<li><a href="#specimen">6. SPECIMEN REQUIREMENTS</a></li>
<li><a href="#reagents">7. REAGENTS AND SUPPLIES</a></li>
<li><a href="#equipment">8. EQUIPMENT</a></li>
<li><a href="#maintenance">9. MAINTENANCE</a></li>
<li><a href="#qc">10. QUALITY CONTROL REQUIREMENTS</a></li>
<li><a href="#calibration">11. CALIBRATION</a></li>
<li><a href="#troubleshooting">12. TROUBLESHOOTING</a></li>
</ul>
</div>
<div class="toc-column">
<ul>
<li><a href="#procedures">13. TEST PROCEDURE</a></li>
<li><a href="#results">14. CALCULATIONS AND RESULT REPORTING</a></li>
<li><a href="#reference">15. REFERENCE RANGES</a></li>
<li><a href="#critical">16. CRITICAL VALUES</a></li>
<li><a href="#limitations">17. LIMITATIONS AND INTERFERENCES</a></li>
<li><a href="#emergency">18. EMERGENCY PROCEDURES</a></li>
<li><a href="#task-reference">19. TASK REFERENCE GUIDE</a></li>
<li><a href="#technical-support">20. TECHNICAL SUPPORT</a></li>
<li><a href="#quality-assurance">21. QUALITY ASSURANCE</a></li>
<li><a href="#regulatory">22. REGULATORY COMPLIANCE</a></li>
<li><a href="#downtime">23. DOWNTIME PROCEDURES</a></li>
<li><a href="#references">24. REFERENCES</a></li>
</ul>
</div>
</div>
</div>

<!-- SECTION 1: PURPOSE -->
<div class="section" id="purpose">
<h2>1. PURPOSE</h2>
<p>This procedure describes standardized methodologies for performing coagulation testing at Kaiser Permanente Largo Laboratory. It encompasses routine coagulation assays including Prothrombin Time (PT/INR), Activated Partial Thromboplastin Time (aPTT), Fibrinogen, D-Dimer, and specialized coagulation studies to support diagnosis and monitoring of bleeding and thrombotic disorders.</p>

<div class="key-concept">
<h4>Key Objectives</h4>
<ul>
<li>Ensure accurate and timely coagulation test results for patient care</li>
<li>Standardize testing procedures across all shifts</li>
<li>Maintain compliance with CLIA, CAP, and Joint Commission standards</li>
<li>Support anticoagulation therapy monitoring</li>
<li>Provide critical results for surgical and emergency care</li>
<li>Minimize pre-analytical variables affecting coagulation testing</li>
</ul>
</div>
</div>

<!-- SECTION 2: SCOPE -->
<div class="section" id="scope">
<h2>2. SCOPE</h2>
<p>This procedure applies to all laboratory personnel performing coagulation testing:</p>
<ul>
<li>Medical Laboratory Scientists (MLS)</li>
<li>Medical Laboratory Technicians (MLT)</li>
<li>Phlebotomists (specimen collection only)</li>
<li>Laboratory Assistants (specimen processing only)</li>
<li>Lead Technologists and Supervisors</li>
<li>Pathology residents and fellows</li>
</ul>

<div class="info-box">
<strong>Testing Locations:</strong> Main Laboratory Coagulation Section<br/>
<strong>Backup Location:</strong> MOB Laboratory - 301-555-2000<br/>
<strong>Operating Hours:</strong> 24/7 with STAT capability
</div>
</div>

<!-- SECTION 3: REGULATORY REQUIREMENTS -->
<div class="section" id="regulatory">
<h2>3. REGULATORY REQUIREMENTS</h2>
<table>
<thead>
<tr>
<th>Regulatory Body</th>
<th>Requirement</th>
<th>Compliance Method</th>
<th>Documentation</th>
</tr>
</thead>
<tbody>
<tr>
<td>CLIA</td>
<td>High Complexity Testing</td>
<td>Qualified personnel only</td>
<td>Competency records</td>
</tr>
<tr>
<td>CAP</td>
<td>HEM.35000-35900</td>
<td>Daily QC, calibration</td>
<td>QC logs, PT results</td>
</tr>
<tr>
<td>Joint Commission</td>
<td>Laboratory Standards</td>
<td>Standardized procedures</td>
<td>Policy compliance</td>
</tr>
<tr>
<td>FDA</td>
<td>510(k) cleared tests</td>
<td>Follow manufacturer IFU</td>
<td>Package inserts</td>
</tr>
<tr>
<td>Kaiser Permanente</td>
<td>Documents 14952_0, 13792_0</td>
<td>Competency requirements</td>
<td>Training records</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 4: TEST PRINCIPLES -->
<div class="section" id="principle">
<h2>4. TEST PRINCIPLES</h2>

<div class="procedure-section">
<h3>Prothrombin Time (PT/INR)</h3>
<p><strong>Principle:</strong> Measures extrinsic and common pathway function</p>
<ul>
<li>Thromboplastin reagent initiates clotting via Factor VII</li>
<li>Optical detection of fibrin clot formation</li>
<li>Results reported in seconds and INR</li>
<li>Primary test for warfarin monitoring</li>
</ul>

<h3>Activated Partial Thromboplastin Time (aPTT)</h3>
<p><strong>Principle:</strong> Measures intrinsic and common pathway function</p>
<ul>
<li>Contact activator and phospholipid initiate clotting</li>
<li>Sensitive to factors VIII, IX, XI, XII</li>
<li>Used for heparin monitoring and factor deficiencies</li>
</ul>

<h3>Fibrinogen</h3>
<p><strong>Principle:</strong> Clauss method - thrombin clotting time</p>
<ul>
<li>Excess thrombin converts fibrinogen to fibrin</li>
<li>Clotting time inversely proportional to fibrinogen level</li>
<li>Critical for bleeding risk assessment</li>
</ul>

<h3>D-Dimer</h3>
<p><strong>Principle:</strong> Immunoturbidimetric assay</p>
<ul>
<li>Monoclonal antibodies detect fibrin degradation products</li>
<li>Marker of fibrinolysis and thrombosis</li>
<li>Used for VTE exclusion</li>
</ul>
</div>
</div>

<!-- SECTION 5: CLINICAL SIGNIFICANCE -->
<div class="section" id="clinical">
<h2>5. CLINICAL SIGNIFICANCE</h2>
<table>
<thead>
<tr>
<th>Test</th>
<th>Clinical Use</th>
<th>Common Abnormalities</th>
</tr>
</thead>
<tbody>
<tr>
<td>PT/INR</td>
<td>Warfarin monitoring, liver disease, DIC screen</td>
<td>Prolonged in vitamin K deficiency, liver failure</td>
</tr>
<tr>
<td>aPTT</td>
<td>Heparin monitoring, hemophilia screening</td>
<td>Prolonged in factor deficiencies, lupus anticoagulant</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td>Bleeding evaluation, DIC diagnosis</td>
<td>Low in DIC, liver disease; High in inflammation</td>
</tr>
<tr>
<td>D-Dimer</td>
<td>DVT/PE exclusion, DIC monitoring</td>
<td>Elevated in thrombosis, pregnancy, malignancy</td>
</tr>
<tr>
<td>Factor Assays</td>
<td>Bleeding disorder diagnosis</td>
<td>Decreased in hemophilia, inhibitors</td>
</tr>
<tr>
<td>Mixing Studies</td>
<td>Differentiate factor deficiency vs inhibitor</td>
<td>Correction = deficiency; No correction = inhibitor</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 6: SPECIMEN REQUIREMENTS -->
<div class="section" id="specimen">
<h2>6. SPECIMEN REQUIREMENTS</h2>

<div class="critical-box">
<h3>Critical Specimen Requirements</h3>
<ul>
<li><strong>Anticoagulant:</strong> 3.2% sodium citrate (light blue top) ONLY</li>
<li><strong>Fill Volume:</strong> MUST fill to line (9:1 blood to citrate ratio)</li>
<li><strong>Mixing:</strong> Gentle inversion 3-4 times immediately</li>
<li><strong>Transport:</strong> Room temperature, upright position</li>
<li><strong>Processing:</strong> Centrifuge within 1 hour of collection</li>
</ul>
</div>

<table>
<thead>
<tr>
<th>Parameter</th>
<th>Requirement</th>
<th>Comments</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tube Type</td>
<td>3.2% sodium citrate (blue)</td>
<td>3.8% citrate NOT acceptable</td>
</tr>
<tr>
<td>Minimum Volume</td>
<td>90% of tube fill</td>
<td>Underfilled tubes alter ratio</td>
</tr>
<tr>
<td>Stability - Whole Blood</td>
<td>4 hours at room temp</td>
<td>For PT/INR and aPTT</td>
</tr>
<tr>
<td>Stability - Plasma</td>
<td>4 hours at room temp</td>
<td>24 hours at 2-8°C if frozen</td>
</tr>
<tr>
<td>Hematocrit Adjustment</td>
<td>Required if Hct <25% or >55%</td>
<td>Adjust citrate volume</td>
</tr>
</tbody>
</table>

<div class="warning-box">
<h3>Specimen Rejection Criteria</h3>
<ul>
<li>Clotted specimens (check with applicator sticks)</li>
<li>Hemolyzed samples (may affect optical endpoint)</li>
<li>Underfilled tubes (<90% of required volume)</li>
<li>Wrong anticoagulant (EDTA, heparin tubes)</li>
<li>Specimens >4 hours old at room temperature</li>
<li>Visible lipemia or icterus (may interfere)</li>
</ul>
</div>
</div>

<!-- SECTION 7: EQUIPMENT -->
<div class="section" id="equipment">
<h2>7. EQUIPMENT</h2>
<table>
<thead>
<tr>
<th>Equipment</th>
<th>Model/Details</th>
<th>Maintenance</th>
</tr>
</thead>
<tbody>
<tr>
<td>Primary Analyzer</td>
<td>Sysmex CS-5100</td>
<td>Daily, weekly, monthly</td>
</tr>
<tr>
<td>Backup Analyzer</td>
<td>Sysmex CS-2500</td>
<td>Same as primary</td>
</tr>
<tr>
<td>Centrifuge</td>
<td>3500 rpm, 15 minutes</td>
<td>Daily balance check</td>
</tr>
<tr>
<td>Refrigerator</td>
<td>2-8°C for reagents</td>
<td>Temperature monitoring</td>
</tr>
<tr>
<td>Freezer</td>
<td>-20°C or -70°C</td>
<td>For specimen storage</td>
</tr>
<tr>
<td>Water Bath</td>
<td>37°C ± 0.5°C</td>
<td>Daily temperature check</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 8: REAGENTS -->
<div class="section" id="reagents">
<h2>8. REAGENTS AND SUPPLIES</h2>
<table>
<thead>
<tr>
<th>Reagent</th>
<th>Storage</th>
<th>Stability</th>
<th>Preparation</th>
</tr>
</thead>
<tbody>
<tr>
<td>PT Reagent (Dade Innovin)</td>
<td>2-8°C</td>
<td>5 days onboard</td>
<td>Reconstitute per IFU</td>
</tr>
<tr>
<td>aPTT Reagent (Actin FSL)</td>
<td>2-8°C</td>
<td>7 days onboard</td>
<td>Ready to use</td>
</tr>
<tr>
<td>Calcium Chloride</td>
<td>Room temp</td>
<td>30 days open</td>
<td>0.025 mol/L</td>
</tr>
<tr>
<td>Fibrinogen Reagent</td>
<td>2-8°C</td>
<td>7 days reconstituted</td>
<td>Thrombin solution</td>
</tr>
<tr>
<td>D-Dimer Reagent</td>
<td>2-8°C</td>
<td>Kit expiration</td>
<td>Ready to use</td>
</tr>
<tr>
<td>Controls (N, Abn 1, Abn 2)</td>
<td>2-8°C</td>
<td>8 hours reconstituted</td>
<td>Reconstitute daily</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 9: QUALITY CONTROL -->
<div class="section" id="qc">
<h2>9. QUALITY CONTROL</h2>

<div class="critical-box">
<h3>Critical QC Rules - NOTIFICATION REQUIRED</h3>
<ul>
<li><strong>1-3s Rule:</strong> One control exceeds ±3 SD - STOP testing</li>
<li><strong>2-2s Rule:</strong> Two consecutive controls exceed ±2 SD same direction</li>
<li><strong>R-4s Rule:</strong> Range between controls exceeds 4 SD</li>
<li><strong>4-1s Rule:</strong> Four consecutive controls exceed ±1 SD same side</li>
<li><strong>10x Rule:</strong> Ten consecutive points on same side of mean</li>
</ul>
<p><strong>Action Required:</strong> Notify Lead Tech immediately, troubleshoot, do not report results</p>
</div>

<table>
<thead>
<tr>
<th>Test</th>
<th>Control Levels</th>
<th>Frequency</th>
<th>Acceptable Range</th>
</tr>
</thead>
<tbody>
<tr>
<td>PT/INR</td>
<td>Normal, Abnormal</td>
<td>Every 8 hours</td>
<td>±2 SD or ±15%</td>
</tr>
<tr>
<td>aPTT</td>
<td>Normal, Abnormal, Heparin</td>
<td>Every 8 hours</td>
<td>±2 SD or ±15%</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td>Normal, Abnormal</td>
<td>With each run</td>
<td>±2 SD or ±20%</td>
</tr>
<tr>
<td>D-Dimer</td>
<td>Negative, Positive</td>
<td>Daily</td>
<td>Per package insert</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 10: CALIBRATION -->
<div class="section" id="calibration">
<h2>10. CALIBRATION</h2>
<table>
<thead>
<tr>
<th>Test</th>
<th>Calibration Type</th>
<th>Frequency</th>
<th>Acceptance</th>
</tr>
</thead>
<tbody>
<tr>
<td>PT/INR</td>
<td>ISI verification</td>
<td>New lot, monthly</td>
<td>ISI ± 0.1</td>
</tr>
<tr>
<td>aPTT</td>
<td>Heparin curve</td>
<td>New lot</td>
<td>R² > 0.98</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td>Multi-point calibration</td>
<td>New lot</td>
<td>Recovery 90-110%</td>
</tr>
<tr>
<td>D-Dimer</td>
<td>Factory calibration</td>
<td>Verify new lot</td>
<td>Control recovery</td>
</tr>
<tr>
<td>Factor Assays</td>
<td>Standard curve</td>
<td>Each run</td>
<td>R² > 0.99</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 11: PROCEDURES -->
<div class="section" id="procedures">
<h2>11. TEST PROCEDURES</h2>

<div class="procedure-section">
<h3>PT/INR Procedure</h3>
<ol>
<li><strong>Specimen Preparation:</strong>
    <ul>
    <li>Verify proper specimen (blue top, filled)</li>
    <li>Check for clots with applicator sticks</li>
    <li>Centrifuge 3500 rpm × 15 minutes</li>
    <li>Obtain platelet-poor plasma (<10,000/µL)</li>
    </ul>
</li>
<li><strong>Analysis:</strong>
    <ul>
    <li>Load specimen on analyzer</li>
    <li>Verify patient demographics</li>
    <li>Select PT/INR test profile</li>
    <li>Analyzer adds thromboplastin and calcium</li>
    <li>Optical detection of clot formation</li>
    </ul>
</li>
<li><strong>Result Review:</strong>
    <ul>
    <li>Check for analyzer flags</li>
    <li>Verify result is within linearity</li>
    <li>Compare with previous results (delta check)</li>
    <li>Calculate INR = (PT patient/PT normal)^ISI</li>
    </ul>
</li>
</ol>
</div>

<div class="procedure-section">
<h3>aPTT Procedure</h3>
<ol>
<li><strong>Pre-analytical:</strong>
    <ul>
    <li>Note if patient on heparin therapy</li>
    <li>Process within 4 hours of collection</li>
    <li>Centrifuge immediately if on heparin</li>
    </ul>
</li>
<li><strong>Testing:</strong>
    <ul>
    <li>Incubate plasma at 37°C</li>
    <li>Add aPTT reagent (activator + phospholipid)</li>
    <li>Incubate 3-5 minutes</li>
    <li>Add calcium chloride</li>
    <li>Measure time to clot formation</li>
    </ul>
</li>
<li><strong>Heparin Specimens:</strong>
    <ul>
    <li>If >100 seconds, perform 1:1 dilution</li>
    <li>Report anti-Xa if available</li>
    <li>Note heparin therapy on report</li>
    </ul>
</li>
</ol>
</div>

<div class="procedure-section">
<h3>Critical Specimen: Mixing Study</h3>
<ol>
<li>Mix patient plasma 1:1 with normal pooled plasma</li>
<li>Perform aPTT immediately and after 2-hour incubation</li>
<li><strong>Interpretation:</strong>
    <ul>
    <li>Correction to normal = factor deficiency</li>
    <li>No correction = inhibitor present</li>
    <li>Time-dependent inhibitor = Factor VIII inhibitor</li>
    </ul>
</li>
</ol>
</div>
</div>

<!-- SECTION 12: RESULTS -->
<div class="section" id="results">
<h2>12. RESULTS AND INTERPRETATION</h2>
<table>
<thead>
<tr>
<th>Pattern</th>
<th>PT/INR</th>
<th>aPTT</th>
<th>Possible Causes</th>
</tr>
</thead>
<tbody>
<tr>
<td>Isolated PT prolongation</td>
<td>↑</td>
<td>Normal</td>
<td>Factor VII deficiency, early warfarin, mild liver disease</td>
</tr>
<tr>
<td>Isolated aPTT prolongation</td>
<td>Normal</td>
<td>↑</td>
<td>Heparin, hemophilia A/B, lupus anticoagulant</td>
</tr>
<tr>
<td>Both prolonged</td>
<td>↑</td>
<td>↑</td>
<td>Common pathway defects, DIC, severe liver disease</td>
</tr>
<tr>
<td>All tests prolonged</td>
<td>↑</td>
<td>↑</td>
<td>Multiple factor deficiencies, anticoagulation</td>
</tr>
</tbody>
</table>

<div class="info-box">
<h4>Therapeutic Ranges</h4>
<ul>
<li><strong>Warfarin (most indications):</strong> INR 2.0-3.0</li>
<li><strong>Warfarin (mechanical valves):</strong> INR 2.5-3.5</li>
<li><strong>Heparin (therapeutic):</strong> aPTT 60-80 seconds (1.5-2.5× baseline)</li>
<li><strong>Direct oral anticoagulants:</strong> Variable effects on routine tests</li>
</ul>
</div>
</div>

<!-- SECTION 13: REFERENCE RANGES -->
<div class="section" id="reference">
<h2>13. REFERENCE RANGES</h2>
<table>
<thead>
<tr>
<th>Test</th>
<th>Reference Range</th>
<th>Units</th>
<th>Critical Values</th>
</tr>
</thead>
<tbody>
<tr>
<td>PT</td>
<td>11.0-13.5</td>
<td>seconds</td>
<td>>30 seconds</td>
</tr>
<tr>
<td>INR (not on warfarin)</td>
<td>0.8-1.2</td>
<td>ratio</td>
<td>>5.0</td>
</tr>
<tr>
<td>aPTT</td>
<td>25-35</td>
<td>seconds</td>
<td>>100 seconds</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td>200-400</td>
<td>mg/dL</td>
<td><100 mg/dL</td>
</tr>
<tr>
<td>D-Dimer</td>
<td><500</td>
<td>ng/mL FEU</td>
<td>N/A</td>
</tr>
<tr>
<td>Thrombin Time</td>
<td>14-19</td>
<td>seconds</td>
<td>>30 seconds</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 14: LIMITATIONS -->
<div class="section" id="limitations">
<h2>14. LIMITATIONS</h2>
<ul>
<li><strong>Pre-analytical Variables:</strong>
    <ul>
    <li>Difficult venipuncture may activate coagulation</li>
    <li>Heparin contamination from lines causes false prolongation</li>
    <li>High hematocrit (>55%) causes false prolongation</li>
    <li>Low hematocrit (<25%) causes false shortening</li>
    </ul>
</li>
<li><strong>Interfering Substances:</strong>
    <ul>
    <li>Direct thrombin inhibitors affect all clot-based tests</li>
    <li>Factor Xa inhibitors variably affect PT and aPTT</li>
    <li>Lupus anticoagulants cause aPTT prolongation without bleeding risk</li>
    <li>High-dose vitamin C may interfere with some methods</li>
    </ul>
</li>
<li><strong>Clinical Limitations:</strong>
    <ul>
    <li>Normal results don't exclude all bleeding disorders</li>
    <li>Platelet function defects not detected</li>
    <li>Von Willebrand disease may have normal screening tests</li>
    </ul>
</li>
</ul>
</div>

<!-- SECTION 15: CRITICAL VALUES -->
<div class="section" id="critical">
<h2>15. CRITICAL VALUES</h2>

<div class="critical-values">
<h3>Critical Value Protocol</h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Critical Value</th>
<th>Action Required</th>
<th>Timeframe</th>
</tr>
</thead>
<tbody>
<tr>
<td>INR</td>
<td>>5.0</td>
<td>Call provider immediately</td>
<td>Within 30 minutes</td>
</tr>
<tr>
<td>PT</td>
<td>>30 seconds</td>
<td>Verify and call</td>
<td>Within 30 minutes</td>
</tr>
<tr>
<td>aPTT (not on heparin)</td>
<td>>100 seconds</td>
<td>Check for heparin, call</td>
<td>Within 30 minutes</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td><100 mg/dL</td>
<td>Verify and call</td>
<td>Within 30 minutes</td>
</tr>
<tr>
<td>New diagnosis hemophilia</td>
<td>Factor <1%</td>
<td>Call hematology</td>
<td>Within 1 hour</td>
</tr>
</tbody>
</table>

<p><strong>Critical Value Notification Procedure:</strong></p>
<ol>
<li>Verify result (repeat if necessary)</li>
<li>Check for pre-analytical issues</li>
<li>Call ordering provider or on-call physician</li>
<li>Document: Time, person notified, read-back confirmation</li>
<li>Enter in critical value log</li>
</ol>
</div>
</div>

<!-- SECTION 16: TAT -->
<div class="section" id="turnaround">
<h2>16. TURNAROUND TIME</h2>
<table>
<thead>
<tr>
<th>Test</th>
<th>Priority</th>
<th>Target TAT</th>
<th>From Receipt</th>
</tr>
</thead>
<tbody>
<tr>
<td>PT/INR</td>
<td>STAT</td>
<td>45 minutes</td>
<td>For surgery, bleeding</td>
</tr>
<tr>
<td>aPTT</td>
<td>STAT</td>
<td>45 minutes</td>
<td>Heparin monitoring</td>
</tr>
<tr>
<td>PT/INR + aPTT</td>
<td>Routine</td>
<td>2 hours</td>
<td>Outpatient monitoring</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td>STAT</td>
<td>1 hour</td>
<td>Bleeding evaluation</td>
</tr>
<tr>
<td>D-Dimer</td>
<td>STAT</td>
<td>1 hour</td>
<td>DVT/PE evaluation</td>
</tr>
<tr>
<td>Factor Assays</td>
<td>Routine</td>
<td>24-48 hours</td>
<td>May batch</td>
</tr>
</tbody>
</table>
</div>

<!-- SECTION 17: MAINTENANCE -->
<div class="section" id="maintenance">
<h2>17. MAINTENANCE</h2>

<div class="procedure-section">
<h3>Daily Maintenance</h3>
<ul>
<li>Clean sample probes with distilled water</li>
<li>Check reagent levels and expiration dates</li>
<li>Verify temperature (analyzer 18-25°C)</li>
<li>Run startup diagnostics</li>
<li>Perform QC before patient testing</li>
<li>Clean work surfaces with 10% bleach</li>
</ul>

<h3>Weekly Maintenance</h3>
<ul>
<li>Thorough probe cleaning with enzymatic cleaner</li>
<li>Clean cuvette area</li>
<li>Check and clean barcode reader</li>
<li>Review QC trends and Levey-Jennings charts</li>
<li>Verify reagent lot numbers in LIS</li>
</ul>

<h3>Monthly Maintenance</h3>
<ul>
<li>Replace tubing as needed</li>
<li>Clean and calibrate pipettes</li>
<li>Temperature verification with certified thermometer</li>
<li>Review error logs and troubleshooting history</li>
<li>Update software if applicable</li>
</ul>
</div>
</div>

<!-- SECTION 18: TROUBLESHOOTING -->
<div class="section" id="troubleshooting">
<h2>18. TROUBLESHOOTING</h2>

<table>
<thead>
<tr>
<th>Problem</th>
<th>Possible Cause</th>
<th>Solution</th>
</tr>
</thead>
<tbody>
<tr>
<td>QC out of range</td>
<td>Reagent deterioration, wrong reconstitution</td>
<td>Check reagents, reconstitute fresh QC</td>
</tr>
<tr>
<td>No clot detected</td>
<td>Severe deficiency, anticoagulant</td>
<td>Dilute sample, manual method</td>
</tr>
<tr>
<td>Erratic results</td>
<td>Fibrin in sample, probe dirty</td>
<td>Re-centrifuge, clean probes</td>
</tr>
<tr>
<td>All tests prolonged</td>
<td>Citrate excess, clotted specimen</td>
<td>Check fill volume, recollect</td>
</tr>
<tr>
<td>Short clotting times</td>
<td>Activated specimen, delay in testing</td>
<td>Recollect, process immediately</td>
</tr>
</tbody>
</table>

<div class="warning-box">
<strong>Technical Support:</strong><br/>
Sysmex: 1-800-800-4566<br/>
Kaiser IT: Extension 5555<br/>
Coagulation Specialist: Pager 1234
</div>
</div>

<!-- SECTION 19: COMPETENCY -->
<div class="section" id="competency">
<h2>19. COMPETENCY ASSESSMENT</h2>

<div class="key-concept">
<h4>Kaiser Permanente Competency Requirements (Documents 14952_0, 13792_0)</h4>
<table>
<thead>
<tr>
<th>Competency Element</th>
<th>Initial</th>
<th>Annual</th>
<th>Method</th>
</tr>
</thead>
<tbody>
<tr>
<td>Test Performance</td>
<td>10 samples each test</td>
<td>5 samples</td>
<td>Direct observation</td>
</tr>
<tr>
<td>QC Performance</td>
<td>All levels</td>
<td>All levels</td>
<td>Documentation review</td>
</tr>
<tr>
<td>Maintenance</td>
<td>All procedures</td>
<td>Key procedures</td>
<td>Checklist</td>
</tr>
<tr>
<td>Result Interpretation</td>
<td>20 cases</td>
<td>10 cases</td>
<td>Case studies</td>
</tr>
<tr>
<td>Critical Values</td>
<td>Simulation</td>
<td>Documentation</td>
<td>Scenario testing</td>
</tr>
<tr>
<td>Troubleshooting</td>
<td>Common problems</td>
<td>New issues</td>
<td>Problem solving</td>
</tr>
</tbody>
</table>
</div>
</div>

<!-- SECTION 20: SAFETY -->
<div class="section" id="safety">
<h2>20. SAFETY</h2>

<div class="warning-box">
<h3>Safety Requirements</h3>
<ul>
<li>Treat all specimens as potentially infectious</li>
<li>Wear gloves, lab coat, and face shield for uncapping</li>
<li>Use splash shields when processing specimens</li>
<li>No mouth pipetting ever</li>
<li>Dispose of sharps in appropriate containers</li>
<li>Clean spills with 10% bleach solution</li>
<li>Report all exposures immediately</li>
</ul>
</div>

<div class="procedure-section">
<h3>Chemical Safety</h3>
<ul>
<li>Review SDS for all reagents</li>
<li>Store reagents at proper temperature</li>
<li>Use fume hood for volatile substances</li>
<li>Calcium chloride: Irritant, avoid skin contact</li>
<li>Thromboplastin: Biological material, handle with care</li>
</ul>
</div>
</div>

<!-- SECTION 21: TRAINING -->
<div class="section" id="training">
<h2>21. TRAINING</h2>

<table>
<thead>
<tr>
<th>Training Phase</th>
<th>Duration</th>
<th>Content</th>
<th>Evaluation</th>
</tr>
</thead>
<tbody>
<tr>
<td>Orientation</td>
<td>1 week</td>
<td>Theory, observation</td>
<td>Written exam</td>
</tr>
<tr>
<td>Hands-on Training</td>
<td>2 weeks</td>
<td>Supervised practice</td>
<td>Skills checklist</td>
</tr>
<tr>
<td>Independent Practice</td>
<td>1 week</td>
<td>Solo with review</td>
<td>Competency assessment</td>
</tr>
<tr>
<td>Advanced Training</td>
<td>Ongoing</td>
<td>Special coagulation</td>
<td>Case reviews</td>
</tr>
</tbody>
</table>

<div class="info-box">
<h4>Required Reading</h4>
<ul>
<li>Manufacturer package inserts</li>
<li>CAP Coagulation checklist</li>
<li>Anticoagulation guidelines</li>
<li>Factor assay procedures</li>
</ul>
</div>
</div>

<!-- SECTION 22: DOWNTIME -->
<div class="section" id="downtime">
<h2>22. DOWNTIME PROCEDURES</h2>

<div class="critical-box">
<h3>Analyzer Failure Protocol</h3>
<ol>
<li><strong>Immediate Actions:</strong>
    <ul>
    <li>Switch to backup analyzer if available</li>
    <li>Notify supervisor and clinicians</li>
    <li>Triage STAT specimens</li>
    </ul>
</li>
<li><strong>Backup Testing:</strong>
    <ul>
    <li>Send STAT PT/INR to MOB Lab: 301-555-2000</li>
    <li>Use manual tilt-tube method for emergency</li>
    <li>POCT INR for critical patients</li>
    </ul>
</li>
<li><strong>Extended Downtime (>4 hours):</strong>
    <ul>
    <li>Route all specimens to MOB Laboratory</li>
    <li>Consider reference lab for specialized tests</li>
    <li>Maintain specimen log for reconciliation</li>
    </ul>
</li>
<li><strong>Recovery:</strong>
    <ul>
    <li>Run QC before resuming testing</li>
    <li>Process backlog by priority</li>
    <li>Verify all results entered correctly</li>
    </ul>
</li>
</ol>
</div>

<div class="info-box">
<strong>Manual PT Method (Emergency Only):</strong><br/>
1. Water bath at 37°C<br/>
2. Add 0.1 mL plasma + 0.1 mL thromboplastin<br/>
3. Incubate 3 minutes<br/>
4. Add 0.1 mL calcium chloride<br/>
5. Tilt tube, record time to clot
</div>
</div>

<!-- SECTION 23: REFERENCES -->
<div class="section" id="references">
<h2>23. REFERENCES</h2>
<ol>
<li>Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays. H21-A5. Wayne, PA: CLSI; 2024.</li>
<li>Clinical and Laboratory Standards Institute (CLSI). One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test. H47-A2. Wayne, PA: CLSI; 2024.</li>
<li>College of American Pathologists (CAP). Hematology and Coagulation Checklist. CAP Accreditation Program. Northfield, IL: CAP; 2024.</li>
<li>Kaiser Permanente. Laboratory Competency Assessment Requirements. Document 14952_0. Oakland, CA: Kaiser Foundation; 2024.</li>
<li>Kaiser Permanente. Technical Competency Standards. Document 13792_0. Oakland, CA: Kaiser Foundation; 2024.</li>
<li>Sysmex CS-5100 Operator Manual, Version 3.0. Sysmex Corporation; 2024.</li>
<li>The Joint Commission. National Patient Safety Goals - Anticoagulation Therapy. Oak Brook, IL: Joint Commission Resources; 2024.</li>
<li>Favaloro EJ, Lippi G. Laboratory Testing in the Era of Direct Oral Anticoagulants. Semin Thromb Hemost. 2024;50(1):15-27.</li>
<li>Kitchen S, et al. International Council for Standardization in Haematology (ICSH) recommendations for laboratory testing of direct oral anticoagulants. Int J Lab Hematol. 2024;46(1):1-9.</li>
<li>Kaiser Permanente Northern California Regional Laboratory Manual. Coagulation Section. 2025 Edition.</li>
</ol>

<div class="info-box">
<h4>Document Control</h4>
<p><strong>Review Frequency:</strong> Annual or with significant changes</p>
<p><strong>Next Review Date:</strong> January 2026</p>
<p><strong>Document Owner:</strong> Coagulation Department Lead</p>
<p><strong>Approved By:</strong> Laboratory Director</p>
<p><strong>Distribution:</strong> All coagulation staff via LIS document portal</p>
</div>
</div>

<!-- FOOTER -->
<div style="margin-top:40px;padding-top:20px;border-top:2px solid #0066cc;text-align:center;color:#666;">
<p><strong>Kaiser Permanente Largo Laboratory</strong></p>
<p>Excellence in Coagulation Testing</p>
<p>© 2025 Kaiser Foundation Health Plan, Inc. All rights reserved.</p>
</div>

</div>
</body>
</html>